-+ 0.00%
-+ 0.00%
-+ 0.00%

Quantum BioPharma files FDA IND for Lucid-MS Phase 2 trial in multiple sclerosis

PUBT·05/07/2026 11:21:20
Listen to the news
Quantum BioPharma files FDA IND for Lucid-MS Phase 2 trial in multiple sclerosis
  • Quantum BioPharma filed an Investigational New Drug application with US FDA for Lucid-MS, clearing regulatory review to support a planned Phase 2 trial in multiple sclerosis.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief on May 07, 2026, and is solely responsible for the information contained therein.